key: cord-0775045-74rl9oal authors: Naouri, Diane; Lapostolle, Frederic; Rondet, Claire; Ganansia, Olivier; Pateron, Dominique; Yordanov, Youri title: Prevention of Medical Events During Air Travel: A Narrative Review date: 2016-06-04 journal: Am J Med DOI: 10.1016/j.amjmed.2016.05.013 sha: 96b6d9dc0789e90b2a82441f6967d4ace5c28f76 doc_id: 775045 cord_uid: 74rl9oal Prior to traveling, and when seeking medical pretravel advice, patients consult their personal physicians. Inflight medical issues are estimated to occur up to 350 times per day worldwide (1/14,000-40,000 passengers). Specific characteristics of the air cabin environment are associated with hypoxia and the expansion of trapped gases into body cavities, which can lead to harm. The most frequent medical events during air travel include abdominal pain; ear, nose, and throat pathologies; psychiatric disorders; and life-threatening events such as acute respiratory failure or cardiac arrest. Physicians need to be aware of the management of these conditions in this unusual setting. Chronic respiratory and cardiovascular diseases are common and are at increased risk of acute exacerbation. Physicians must be trained in these conditions and inform their patients about their prevention. International tourism is one of the leading points of the world economy. 1 In 2009, more than 59% of travel was by air, 1 and according to the World Tourism Organization, tourism represents up to 50% of air travel, before business travel (15%) and travel to visit friends and relatives (27%). Since the establishment in 1919 of the first airline company, air traffic continues to increase, with an estimated average annual growth of 4%. 1 In 2008, almost 2 billion people traveled by commercial airlines. 2 With the increased number of passengers per year, the number of miles flown and passengers boarding is also increasing. In 2013, the maximum number of passengers authorized to board the airbus A380 was 853 per flight. 3 Medical issues during air travel are estimated at about 350 per day worldwide, corresponding to 1/14,000-40,000 passengers. 4 Because of the specific characteristics of air cabin environment, air travel can exacerbate passengers' underlying conditions, for increased risk of medical emergencies. However, unlike ground travel, air travel raises the question of the availability of advanced care in case of medical issues and their management. Health care providers and travelers need to be aware of the potential medical issues associated with air travel and their prevention. Among all medical problems on board, some might be life threatening, such as cardiac issues. 5 Some others are predictable and therefore preventable, such as pulmonary issues, 6, 7 which suggests that prevention of medical issues related to air travel is highly important in primary and secondary care. General practitioners often provide pretravel medical advice, most commonly for immunizations and malaria chemoprophylaxis. 8 They also frequently advise certain patient groups such as cardiovascular patients and pregnant women. 8 General practitioners are often the first physicians consulted prior to departure. [9] [10] [11] However, other sources for travel health advice include travel clinics, travel agents, pharmacists, family and friends, the Internet, books, brochures, and newspapers. 9, 10 This clearly illustrates the variety of sources consulted, and the fact that travelers are aware of the need to obtain information and be prepared prior to traveling. Several studies have investigated the determinants of consulting a general practitioner prior to departure. Male sex, 12,13 age <50 years, [12] [13] [14] travel to a nonmalarial region, 13 foreign nationality, and previous travel experience 12, [14] [15] [16] are negatively associated with the likelihood to consult. Frequency of pretravel consultations with specialized physicians other than general practitioners remains poorly documented. In this context, 3 issues are currently debated: in-flight emergencies and their management, common underlying conditions at risk of exacerbation during the flight and their prevention, and the main situations justifying a priori specific care. In this paper, we review these 3 issues. The earth's atmosphere is defined by its pressure, composition, and temperature. Air pressure and temperature depend on the altitude. When the altitude increases, barometric pressure and temperature decrease according to an exponential curve ( Figure) . At cruising altitude (10,000 to 13,000 m above sea level), temperature outside the aircraft is about À54 C and the atmospheric pressure is about 240 hPa. With decreasing barometric pressure, oxygen partial pressure also decreases (according to Dalton's law), and gases trapped within body cavities expand (according to the Boyle-Mariotte law). Thus, aviation regulation requires that all aircraft carrying passengers must be pressurized and maintain a cabin altitude of about 2438 m. Moreover, cabin air is first drawn from outside the aircraft and then heated, filtered, and recirculated, which results in very low humidity, about 10% to 20%. In 1998, the US Aviation Medical Assistance Act was passed. Its goal was to protect physicians who respond to medical emergencies on board against liability, except in cases of gross negligence or willful misconduct. 17 In emergency cases, the care provided and treatments delivered should be documented. Because of probable underreporting, the exact number of medical issues during air travel is difficult to assess. Most in-flight medical events may be minor, because diversions may occur in 7% to 13% of cases, 18 and deaths are estimated at about 0.3 to 1 per million passengers per year. 19 Medical advice is obtained on board in 69% of cases from physicians (40%), nurses (25%), or paramedics (4%). 4 The most common causes of medical events on board are gastrointestinal diseases or troubles (25%). 4,5 Among all medical events, cardiac arrest is rare, about 1000 cases per year, but is responsible for 86% of deaths on board. 20 Here, we focus on cardiac arrest and the most common causes of medical events on board. It is no longer debated that early defibrillation is related to survival after cardiac arrest 21 ; therefore, the presence on board of automated external defibrillators appears necessary. Qantas (Mascot, NSW, Australia) was the first airline to equip their aircraft with automated external defibrillators, in 1992. 22 During a 65-month period, 27 cardiac arrests were reported, with 2 cases of long-term survival. 22 A study estimated that deploying automated external defibrillators on all aircraft would save approximately 33 lives per year, and automated external defibrillator deployment on large-and mediumcapacity aircraft would cost <$50,000 per quality-adjusted life-year gained. 23 Since then, most airlines have equipped their aircraft with automated external defibrillators and trained staff in basic cardiopulmonary resuscitation. Gastrointestinal pathologies are mainly due to the expansion of bowel gas. In most cases, this situation is responsible for The most common in-flight medical issues are gastrointestinal pathologies (mainly abdominal pain), psychiatric disorders, and ear, nose, and throat pathologies (mainly barotitis). Most could be prevented with appropriate pretravel advice or medical treatment. Some underlying conditions are at higher exacerbation risk during air travel and require an assessment of ability to fly. Respiratory and cardiovascular exacerbations are predictable in most cases, and can be avoided with appropriate prevention. The American Journal of Medicine, Vol 129, No 9, September 2016 isolated abdominal pain. To prevent this event, current guidelines recommend avoiding the consumption of soft drinks and foods at risk of fermentation during and prior to the flight. Gas expansion can be a contraindication for travel, for example, in case of sub-occlusion, diverticulitis, and ulcerated colitis. 24 Patients who have undergone recent surgery or colonoscopy should not fly for 24 hours after colonoscopy, and 5 to 10 days for coelioscopic and noncoelioscopic surgery. 24 Psychiatric issues constitute 3.5% of in-flight medical emergencies, many (90%) presenting primarily as acute anxiety. The fear of flying is estimated to concern 10% to 40% of passengers and increases with enhanced security measures, delayed flights, cramped cabins, and alcohol consumption. 25, 26 Incidents of in-flight passenger misconduct represent a serious threat to passenger safety. This situation corresponds to 1% per 2 million passengers, on average. 27 Excessive alcohol use and illegally smoking on board aircraft are implicated in more than 80% of incidents. 27 The typical passenger at risk of misconduct is a male 30 to 49 years old. 27 Ear, Nose, and Throat Pathologies One of the most common causes of premature incapacitation for work among aircrew is barotrauma induced by pressure changes during air travel. 28 Equilibration is normally achieved by swallowing, jaw movements, yawning, or chewing, but with upper respiratory infection, the equilibration process might fail and cause barotitis or aerosinusitis. The incidence of barotitis has been estimated at 10% among adults and 22% among children. 29 For people regularly exposed, the use of an oral decongestant prior to flying decreases the incidence of middle-ear barotrauma. 30, 31 An autoinflation device (Otovent; ABIGO Medical AB, Askim, Sweden) is also recommended for passengers with problems clearing the ears during flights. 32 As seen above, air travel is associated with decreased partial pressure of oxygen. In healthy subjects, the condition is asymptomatic. However, with underlying conditions, hypoxia can exacerbate previous diseases, especially respiratory and cardiac pathologies. The effect of decreased barometric pressure and partial pressure of oxygen with air flight is generally limited by the shape of the hemoglobin dissociation curve and thus, is usually asymptomatic. In healthy subjects, the mean SpO 2 decreases from 97% at sea level to 93% at 2438 m. 33, 34 However, this exposure may affect people with lung disease, especially if they are hypoxemic prior to travel, because flying involves the steeper part of the dissociation curve. In addition, air travel is associated with an expansion of gases trapped and lowered air humidity. All these conditions can lead to acute exacerbation of chronic obstructive pulmonary disease, asthma, and other lung diseases. [35] [36] [37] Several measures are available for evaluating supplemental oxygen needs during flight. The pulse oxymeter 38 and the 50-m walk test 39 are simple tests achievable in ambulatory care even if they have some limitations. 38, 40, 41 They allow for screening patients for whom specialized evaluation is needed, particularly by the hypoxia test. 38 For safety reasons, the US Federal Aviation Administration does not allow travelers to carry their own liquid oxygen aboard aircrafts. Airlines can provide oxygen during the travel at the request of a doctor (2 or 4 L/min), but they do not provide oxygen for ground use. Instead, most patients can use a portable oxygen concentrator. Airline authorization is recommended to allow use of these devices throughout the flight. Cardiac diseases represent 10% of medical incidents on board, are the first cause of diversion, 5 and represent 56% of deaths on flights. 42 The most common cause of cardiac events on flights is a vasovagal episode. 19 However, with less oxygen available for cardiac cellular metabolism (secondary to hypoxemia), ischemic events can occur, particularly in the days following a previous myocardial infarction. 43, 44 Many guidelines concerning myocardial infarction related to air travel are available. The expert panels recommend waiting from 3 days to 8 weeks prior to air travel after uncomplicated myocardial infarction (defined as confirmed myocardial infarction without recurrent angina, dysrhythmia, and pump failure). 34, [45] [46] [47] Limited data are available on air travel after complicated myocardial infarction, defined as myocardial infarction with any of the following events occurring in the peri-or postinfarction period: recurrent ischemia, compromising dysrhythmia, and pump failure (congestive heart failure or significant hypotension). Experts recommend delaying air travel from 2 to 6 weeks. 34, 45, 46 Only a few studies are available regarding congestive heart failure and air travel. 48, 49 In 2010, Smith et al 34 produced a report on fitness to fly for passengers with cardiovascular disease. With congestive heart failure, short-term (up to 1 hour) hypoxia at rest was associated with no significant adverse effects (including patients with New York Heart Association class III/IV symptoms). Longer-term hypoxia (up to 7 hours) was tolerated in patients with mild-to-moderate stable congestive heart failure. Following an episode of acute heart failure, the authors recommended waiting 6 weeks after stabilization prior to flying. 34 Patients with stable congestive heart failure have no restrictions on flying, but for those with severe limitations (New York Heart Association class III/IV), airport assistance and oxygen supplementation should be considered. 34 Finally, hypoxia and the associated increase in alpha-and beta-adrenergic stimulation may increase the susceptibility to arrhythmia, but few data are available. According to Smith et al, 34 hypoxia is not associated with increased susceptibility to arrhythmia or any adverse effect on pacing threshold at cabin altitudes encountered during air travel. However, atrial fibrillation or ventricular arrhythmias should be controlled prior to flying. For people with pacemakers or implantable cardioverter defibrillators, the risk of electromagnetic interferences due to metal detector gates is minimal. 50, 51 However, the security staff should be alerted to the presence of the device because the metal casing of the device may activate the alarm. Prolonged air travel increases the risk of venous thromboembolism (pooled relative risk 2.8; 95% confidence interval, 2.2-3.7) and a dose-response effect: each 2 hours of travel is associated with an 18% increased risk of venous thromboembolism. [52] [53] [54] The association between air travel and venous thromboembolism is the strongest with travel for 8 to 10 hours [26] [27] [28] and the presence of venous thromboembolism risk factors, including previous venous thromboembolism, recent surgery, active malignancy, pregnancy, estrogen use, advanced age, limited mobility, severe obesity, or thrombophilic disorders. [55] [56] [57] [58] However, the global risk of (severe) pulmonary embolism is about 0.4 cases/million passengers. 59 The risk reaches 5 cases/million for travel >10,000 km, with an excess risk among women. 60 Thus, long-distance travelers (ie, >6 hours) with one venous thromboembolism risk factor should perform frequent ambulation and calf muscle exercise, sit in an aisle seat if feasible, and use graduated compression stockings (Grade 2C). 58 Recommendations are also against the use of aspirin or anticoagulants (Grade 2C) due to lack of data on this subject. 58 More studies are needed to assess the value of such treatments in venous thromboembolism prevention. Cabin air quality depends on a ventilation system, air filtration, and humidity. Because the aircraft cabin is a confined space, airborne, food-borne, vector-borne, and zoonotic infectious diseases transmitted during commercial air travel are an important public health issue. The severe acute respiratory syndrome outbreak of 2002 showed the potential role of air travel in the rapid spread of emerging infections. 61 The risk of disease transmission within the confined space of the aircraft cabin is difficult to determine. It depends on cabin ventilation, [61] [62] [63] with the flow rate the most important element. Airflow in aircraft is described as laminar, but air emerging above one row is considered to be shared mainly with that row and the 2 adjacent rows in front and behind. 62 Despite limitations related to reporting bias caused by incomplete passenger manifests, data from several studies suggest that risk of air transmission of infection to other passengers in the aircraft is associated with sitting within 2 rows of a contagious passenger for a flight time of more than 8 hours. 61, 64, 65 CONCLUSION Medical issues related to air travel are relatively frequent. In most cases, they are related to underlying conditions and could have been easily avoided through appropriate prevention. Health care providers need to be aware of the potential medical issues associated with air travel and their prevention. Le poids économique et social du tourisme European Aviation Safety Agency. EASA type-certificate data sheet for Airbus A380 Y a t-il un médecin dans l'avion? Medical assistance during commercial airline flights: analysis of 11 years experience of the Paris emergency medical service (SAMU) between 1989 and 1999 Sleep-disordered breathing Voyage aerien et maladies respiratoires Nationwide survey of the role of travel medicine in primary care in Germany Knowledge, attitudes and practices in travel-related infectious diseases: the European airport survey Travelers' knowledge, attitudes, and practices on prevention of infectious diseases: results from a pilot study Prevention of travel-related infectious diseases: knowledge, practices and attitudes of Swedish travellers A cross-sectional study of pre-travel health-seeking practices among travelers departing Sydney and Bangkok airports Are French general practitioners consulted before travel to developing countries? A crosssectional study conducted in a French airport Predictors of pretravel consultation in tourists from Quebec (Canada) Spanish travelers to high-risk areas in the tropics: airport survey of travel health knowledge, attitudes, and practices in vaccination and malaria prevention Pre-travel health adviceseeking behavior among US international travelers departing from Boston Logan International Airport ER in the skies: in-flight medical emergencies Commercial aviation in-flight emergencies and the physician Management of in-flight medical emergencies Outcomes of medical emergencies on commercial airline flights A cumulative meta-analysis of the effectiveness of defibrillator-capable emergency medical services for victims of out-of-hospital cardiac arrest An airline cardiac arrest program Cost-effectiveness of automated external defibrillators on airlines Medical aspects of commercial air travel In-flight medical emergencies during commercial travel Psychological factors in airline passenger and crew behaviour: a clinical overview Trends in disruptive passenger behaviour on board UK registered aircraft Upper respiratory infections and barotraumas in commercial pilots: a retrospective survey Middle ear pain and trauma during air travel A double-blind comparison between oral pseudoephedrine and topical oxymetazoline in the prevention of barotrauma during air travel Efficacy of pseudoephedrine for the prevention of barotrauma during air travel Point prevalence of barotitis in children and adults after flight, and effect of autoinflation The effect of high altitude commercial air travel on oxygen saturation. Anaesthesia Fitness to fly for passengers with cardiovascular disease Is air travel safe for those with lung disease? Effect of hypobaric hypoxia on blood gases in patients with restrictive lung disease High prevalence of respiratory symptoms during air travel in patients with COPD Managing patients with stable respiratory disease planning air travel: a primary care summary of the British Thoracic Society recommendations Hypoxaemia in chronic obstructive pulmonary disease patients during a commercial flight Accuracy of oxyhemoglobin saturation monitors during simulated altitude exposure of men with chronic obstructive pulmonary disease Air travel and respiratory diseases. Medical manual Cardiovascular disease and aircraft transportation: specificities and issues Safety of commercial air travel following myocardial infarction Long-distance air travel soon after an acute coronary syndrome: a prospective evaluation of a triage protocol ACC/AHA guideline for the management of patients with STEMI: the implications for clinicians Aerospace Medical Association Medical Guidelines Task Force. Medical Guidelines for Airline Travel Assessment of the cardiac patient for fitness to drive and fly: executive summary Effects of reducing inspired oxygen concentration for one hour in patients with chronic heart failure: implications for air travel Effects of simulated altitudeinduced hypoxia on exercise capacity in patients with chronic heart failure Do airport metal detectors interfere with implantable pacemakers or cardioverter-defibrillators? The effect of metal detector gates on implanted permanent pacemakers Meta-analysis: travel and risk for venous thromboembolism Travel and venous thrombosis: a systematic review Travel and risk of venous thrombosis Venous thrombosis after longhaul flights Risk of venous thromboembolism after air travel: interaction with thrombophilia and oral contraceptives Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis Incidence of air travelrelated pulmonary embolism at the Madrid-Barajas airport Severe pulmonary embolism associated with air travel Transmission of infectious diseases during commercial air travel Air travel and TB: an airline perspective Tuberculosis and Air Travel: Guidelines for Prevention and Control World Health Organization (WHO) Transmission of the severe acute respiratory syndrome on aircraft The authors thank Laura Smales (BioMedEditing) for editing.